NCT05577338

Brief Summary

Background: Presence of a series of typical physical symptoms is an enduring and functionally relevant feature of early-onset schizophrenia (EOS). Psychotherapy improves clinical symptoms in adults with schizophrenia, although data in adolescents with EOS remain scarce. The purpose of this study is to examine the efficacy of the adapted group psychotherapy in improving clinical symptoms from a perspective of neuroimaging in a sample of symptomatically stable adolescents with EOS. Methods: Investigators conducted a double-blind randomized controlled trial using multidomain, adaptive, group psychotherapy in 28 EOS patients, who were randomly allocated into either training (group psychotherapy) or active control (health education) groups. Data of diffusion tensor imaging, and clinical symptoms were obtained at baseline and after an average of 2 hours/day, 2 days/week for 4 weeks of intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
Last Updated

September 13, 2023

Status Verified

August 1, 2021

Enrollment Period

3.1 years

First QC Date

September 19, 2022

Last Update Submit

September 11, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • changes in positive and negative scale score (PANSS)

    A standardized rating scale of clinical questionnaires without units designed to assess the severity of symptoms of different types of schizophrenia.

    Change from Baseline PANSS at 1 month

  • changes in binary betweenness centrality

    One of the brain structural network properties computed via the software packages Brain functional Magnetic Resonance Imaging (FMRIB) Software Library (FSL3) and Diffusion Toolkit (DTK4) without units and captures the extent to which a node is in-between several other nodes in a network.

    Change from Baseline binary betweenness centrality at 1 month

Study Arms (2)

training group

EXPERIMENTAL

Theory of Mind psychotherapy psychotherapy

Behavioral: Theory of Mind psychotherapy

active control group

ACTIVE COMPARATOR

receive disease-related health knowledge

Behavioral: health education

Interventions

a semi-structured, multidomain, tailored group psychotherapy

training group

disease-related health knowledge

active control group

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Clinical diagnosis of EOS
  • Right-handed subjects
  • Aged 13 - 18 years old
  • Capable of understanding, judgments and expression

You may not qualify if:

  • The presence of other psychiatric disorders such as substance-induced mood disorder, bipolar disorders, anxiety disorders, substance abuse, or dependence
  • A history of significant physical or neurological disease
  • A history of head injury with loss of consciousness
  • A history of electroconvulsive therapy
  • Contraindications for MRI such as claustrophobia
  • Mental retardation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, 230022, China

Location

Related Publications (5)

  • Kumra S, Charles Schulz S. Editorial: research progress in early-onset schizophrenia. Schizophr Bull. 2008 Jan;34(1):15-7. doi: 10.1093/schbul/sbm123. Epub 2007 Nov 28.

    PMID: 18048380BACKGROUND
  • Vernal DL, Boldsen SK, Lauritsen MB, Correll CU, Nielsen RE. Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study. Schizophr Res. 2020 Jun;220:123-129. doi: 10.1016/j.schres.2020.03.045. Epub 2020 Apr 13.

    PMID: 32299717BACKGROUND
  • Armando M, Pontillo M, Vicari S. Psychosocial interventions for very early and early-onset schizophrenia: a review of treatment efficacy. Curr Opin Psychiatry. 2015 Jul;28(4):312-23. doi: 10.1097/YCO.0000000000000165.

    PMID: 26001923BACKGROUND
  • Puig O, Penades R, Baeza I, De la Serna E, Sanchez-Gistau V, Bernardo M, Castro-Fornieles J. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):859-68. doi: 10.1016/j.jaac.2014.05.012. Epub 2014 Jun 21.

    PMID: 25062593BACKGROUND
  • Liu S, Zhong H, Qian Y, Cai H, Jia YB, Zhu J. Neural mechanism underlying the beneficial effect of Theory of Mind psychotherapy on early-onset schizophrenia: a randomized controlled trial. J Psychiatry Neurosci. 2023 Nov 7;48(6):E421-E430. doi: 10.1503/jpn.230049. Print 2023 Nov-Dec.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2022

First Posted

October 13, 2022

Study Start

August 1, 2018

Primary Completion

August 30, 2021

Study Completion

September 30, 2021

Last Updated

September 13, 2023

Record last verified: 2021-08

Locations